Toggle navigation
Home
Search
Services
Blog
Contact
About
Single Primer Mediated Cloning of P53 Regulated Genes
Passavant, Charles W.
Cascade Oncogenics, Inc., Portland, OR, United States
Search 6 grants from Charles Passavant
Search grants from Cascade Oncogenics, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development of Fluorogenic Aptamers for Detection and Deactivation of Erbb Receptors using Bifacial PNA
Towards Optimal treatment matching for brief motivational interventions
Functions of C-Fos Protein in Cellular Physiology
EAGER: Monitoring the Global Electric Circuit from Ocean Straits
Development of a Micro-Optical Stress Sensor for Fluid Mechanics Research
Recently added grants:
Elucidating the trophic support of long axons by metabolic signaling in oligodendrocytes
Ultrafast Quantitative pH MRI for Acute Ischemic Stroke Patients
Role of the Kinesin KIF1A in Neurological Disease
High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells
Rapid evaluation of immunotherapy regimens in ex vivo human pancreatic tumor slice cultures.
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
9R44CA072451-02
Application #
2010543
Study Section
Special Emphasis Panel (ZRG2-SSS-Y (09))
Project Start
1996-09-30
Project End
1998-09-29
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Cascade Oncogenics, Inc.
Department
Type
DUNS #
City
Portland
State
OR
Country
United States
Zip Code
97201
Related projects
NIH 1997
R44 CA
Single Primer Mediated Cloning of P53 Regulated Genes
Passavant, Charles W. / Cascade Oncogenics, Inc.
NIH 1996
R44 CA
Single Primer Mediated Cloning of P53 Regulated Genes
Passavant, Charles W. / Cascade Oncogenics, Inc.
Comments
Be the first to comment on Charles Passavant's grant